Sachiko Ozawa
Cited by
Cited by
Global Economic Burden of Norovirus Gastroenteritis
SM Bartsch, BA Lopman, S Ozawa, AJ Hall, BY Lee
PLOS ONE 11 (4), e0151219, 2016
How do you measure trust in the health system? A systematic review of the literature
S Ozawa, P Sripad
Social Science & Medicine 91, 10-14, 2013
Return On Investment From Childhood Immunization In Low-And Middle-Income Countries, 2011–20
S Ozawa, S Clark, A Portnoy, S Grewal, L Brenzel, DG Walker
Health Affairs 35 (2), 199-207, 2016
Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review
S Ozawa, A Mirelman, ML Stack, DG Walker, OS Levine
Vaccine 31 (1), 96-108, 2012
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low-and Middle-Income Countries: A Systematic Review and Meta-analysis
S Ozawa, DR Evans, S Bessias, DG Haynie, TT Yemeke, SK Laing, ...
JAMA Network Open 1 (4), e181662-e181662, 2018
Sustainability of donor programs: evaluating and informing the transition of a large HIV prevention program in India to local ownership
S Bennett, S Singh, S Ozawa, N Tran, JS Kang
Global health action 4 (1), 7360, 2011
Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States
S Ozawa, A Portnoy, H Getaneh, S Clark, M Knoll, D Bishai, HK Yang, ...
Health Affairs 35 (11), 2124-2132, 2016
Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity
ML Stack, S Ozawa, DM Bishai, A Mirelman, Y Tam, L Niessen, ...
Health Affairs 30 (6), 1021-1028, 2011
Estimated economic impact of vaccinations in 73 low-and middle-income countries, 2001–2020
S Ozawa, S Clark, A Portnoy, S Grewal, ML Stack, A Sinha, A Mirelman, ...
Bulletin of the World Health Organization 95 (9), 629, 2017
Comparison of trust in public vs private health care providers in rural Cambodia
S Ozawa, DG Walker
Health Policy and Planning 26 (suppl_1), i20-i29, 2011
Public trust and vaccine acceptance-international perspectives
S Ozawa, ML Stack
Human vaccines & immunotherapeutics 9 (8), 1774-1778, 2013
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
PN Newton, KC Bond, M Adeyeye, M Antignac, A Ashenef, GR Awab, ...
The Lancet Global Health 8 (6), e754-e755, 2020
Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency
A Mirelman, E Mentzakis, E Kinter, F Paolucci, R Fordham, S Ozawa, ...
Value in health 15 (3), 534-539, 2012
During the ‘decade of vaccines,’the lives of 6.4 million children valued at $231 billion could be saved
S Ozawa, ML Stack, DM Bishai, A Mirelman, IK Friberg, L Niessen, ...
Health Affairs 30 (6), 1010-1020, 2011
10 best resources on… mixed methods research in health systems
S Ozawa, K Pongpirul
Health policy and planning 29 (3), 323-327, 2014
Costs of vaccine programs across 94 low-and middle-income countries
A Portnoy, S Ozawa, S Grewal, BA Norman, J Rajgopal, KM Gorham, ...
Vaccine 33, A99-A108, 2015
Exploring pathways for building trust in vaccination and strengthening health system resilience
S Ozawa, L Paina, M Qiu
BMC health services research 16 (7), 131-141, 2016
Reassessing the value of vaccines
T Bärnighausen, S Berkley, ZA Bhutta, DM Bishai, MM Black, DE Bloom, ...
The Lancet Global Health 2 (5), e251-e252, 2014
Trust in the context of community-based health insurance schemes in Cambodia: villagers’ trust in health insurers
S Ozawa, DG Walker
Adv Health Econ Health Serv Res 21, 107-132, 2009
The economic impact of substandard and falsified antimalarial medications in Nigeria
SM Beargie, CR Higgins, DR Evans, SK Laing, D Erim, S Ozawa
PloS one 14 (8), e0217910, 2019
The system can't perform the operation now. Try again later.
Articles 1–20